Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
307.251129305
InChI
InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3
InChI Key
InChIKey=KKGQTZUTZRNORY-UHFFFAOYSA-N
IUPAC Name
2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
Traditional IUPAC Name
fingolimod
SMILES
CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
pKa (strongest acidic)
14.41
pKa (Strongest Basic)
9.38
Refractivity
93.28 m3·mol-1
Cơ Chế Tác Dụng :
FTY-720 is an orally active immunosuppressant, under development by Mitsubishi Pharma for use in transplantation and autoimmune diseases. It reduces the number of lymphocytes in the blood by redirecting them to the lymph nodes. FTY-720 is currently in phase II evaluation in a cohort of kidney transplant patients and is expected to enter phase II trials this year with registration filing expected in 2005, with launch in 2006.
FTY720 is the first of a new drug class: sphingosine-1-phosphate receptor agonist. Its effect relates to the modulation of lymphocytes trafficking from blood and peripheral tissues to the lymph nodes. Unlike conventional immunosuppressants, FTY720 does not impair the activation, proliferation, or effector functions of T and B cells
Chỉ Định :
Investigated for use/treatment in immunosuppressive, multiple sclerosis, and transplant (rejection).